Skip to main content
. 2022 Jul 18;14(14):3492. doi: 10.3390/cancers14143492

Table 1.

Patient characteristics.

Training Validation p
Age 44.06 ± 14.00 49.76 ± 13.44 0.040399 *
Gender Male 26 23 0.088934
Female 37 19
Histology Astrocytoma 21 11 0.127063
Oligoastrocytoma 18 10
Oligodendroglioma 24 21
Grade II 26 20 0.262543
III 37 22
Subtype Classic-like 2 3 0.09987
Codel 13 15
G-CIMP-high 38 16
G-CIMP-low 2
Mesenchymal-like 6 7
PA-like 2 1
Vital status Dead 13 13 0.117054
Alive 29 50
IDH status Mutant 53 31 0.099583
Wildtype 10 11
1p_19q codeletion status Codel 13 14 0.073916
Non-codel 50 28
MGMT promoter status Methylated 51 39 0.045106 *
Unmethylated 12 3
TMB group TMB high 25 18 0.37498
TMB low 38 24

* statistically significant with p < 0.05.